Bifurcation kinetics of drug uptake by Gram-negative bacteria. 2017

David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
Department of Chemistry and Biochemistry, University of Oklahoma, Stephenson Parkway, Norman, OK, United States of America.

Cell envelopes of many bacteria consist of two membranes studded with efflux transporters. Such organization protects bacteria from the environment and gives rise to multidrug resistance. We report a kinetic model that accurately describes the permeation properties of this system. The model predicts complex non-linear patterns of drug uptake complete with a bifurcation, which recapitulate the known experimental anomalies. We introduce two kinetic parameters, the efflux and barrier constants, which replace those of Michaelis and Menten for trans-envelope transport. Both compound permeation and efflux display transitions, which delineate regimes of efficient and inefficient efflux. The first transition is related to saturation of the transporter by the compound and the second one behaves as a bifurcation and involves saturation of the outer membrane barrier. The bifurcation was experimentally observed in live bacteria. We further found that active efflux of a drug can be orders of magnitude faster than its diffusion into a cell and that the efficacy of a drug depends both on its transport properties and therapeutic potency. This analysis reveals novel physical principles in the behavior of the cellular envelope, creates a framework for quantification of small molecule permeation into bacteria, and should invigorate structure-activity studies of novel antibiotics.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.

Related Publications

David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
May 2003, Frontiers in bioscience : a journal and virtual library,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
March 1957, Journal of bacteriology,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
December 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
January 1986, Microbios,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
February 2019, Analytical chemistry,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
May 1971, Proceedings of the Royal Society of Medicine,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
December 1968, Nihon Densenbyo Gakkai zasshi,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
April 1971, Revista brasileira de medicina,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
September 1958, Nature,
David A Westfall, and Ganesh Krishnamoorthy, and David Wolloscheck, and Rupa Sarkar, and Helen I Zgurskaya, and Valentin V Rybenkov
January 2018, Infection and drug resistance,
Copied contents to your clipboard!